The relationship of cardiovascular risk factors to alzheimer disease in choctaw indians

American Journal of Geriatric Psychiatry

Volumn 19, Issue 5, 2011, Pages 423-429

  Weiner, Myron F ^a,b,c   Hynan, Linda S ^a   Rossetti, Heidi ^a   Womack, Kyle B ^b   Rosenberg, Roger N ^b   Gong, Yun Hua ^b   Qu, Bao Xi ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c NONE   (United States)

Author keywords

Alzheimer disease; American Indian; apolipoprotein E; cardiovascular risk; homocysteine

Indexed keywords

ANTILIPEMIC AGENT; APOLIPOPROTEIN E4; CHOLESTEROL; HOMOCYSTEINE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE PREDISPOSITION; FEMALE; GENE FREQUENCY; GENOTYPE; HEART INFARCTION; HIGH RISK POPULATION; HUMAN; HYPERTENSION; INDIAN; MALE; ONSET AGE;

EID: 79955472636     PISSN: 10647481     EISSN: 15457214     Source Type: Journal    
DOI: 10.1097/JGP.0b013e3181e89a46     Document Type: Article

References (35)

1. Bhargava D, Weiner MF, Hynan LS, et al: Vascular disease and risk factors, rate of progression, and survival in Alzheimer's disease. J Geriatr Psychiatry Neurol 2006; 19:78-82. (Pubitemid 43726026)
2. Corbo RM, Scacchi R: Apolipoprotein E (APOE) allele distribution in the world. Is APOE?4 a 'thrifty' allele? Ann Hum Genet 1999; 63:301-310. (Pubitemid 30021229)
3. Strong Heart Data Book. NIH Publication 01-3285. Washington, aq: 14 DC, U.S. Government Printing Office, 2001.
4. Hertz RP, Unger AN, Cornell JA, et al: Racial disparities in hypertension prevalence, awareness, and management. Arch Intern Med 2005; 165:2098-2104. (Pubitemid 41434584)
5. Hamman RF, Marshall JA, Baxter J, et al: Methods and prevalence of noninsulin-dependent diabetes mellitus in a biethnic Colorado population. San Luis Valley Diabetes Study. Am J Epidemiol 1989; 129:295-311. (Pubitemid 19046996)
6. Henderson JN, Crook R, Crook J, et al: Apolipoprotein E4 and tau allele frequencies among Choctaw Indians. Neurosci Lett 2002; 324:77-79. (Pubitemid 34442682)
7. Rosenberg RN, Richter RW, Risser RC, et al: Genetic factors for the development of Alzheimer's Disease in the Cherokee Indian. Arch Neurol 1996; 53:997-1000. (Pubitemid 26340035)
8. Gureje O, Ogunniyi A, Baiyewu O, et al: APOE epsilon 4 is not associated with Alzheimer's disease in elderly Nigerians. Ann Neurol 2006; 59:182-185. (Pubitemid 43042886)
9. Hendrie HC, Hall KS, Pillay N, et al: Alzheimer's disease is rare in Cree. Int Psychogeriatr 1993; 5:5-14. (Pubitemid 23144201)
10. Simons M, Keller P, Dichgans J, et al: Cholesterol and Alzheimer's disease. Is there a link? Neurology 2001; 57: 1089-1093. (Pubitemid 32880208)
11. Zandi PP, Sparks DL, Khachaturian AS, et al: Do statins reduce risk of incident dementia and Alzheimer disease? The Cache County Study Arch Gen Psychiatry 2005; 62:217224.
12. Notkola IL, Sulkava R, Pekkanen J, et al: Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease. Neuroepidemiology 1998; 17:14-20. (Pubitemid 28153361)
13. Kivipelto M, Helkala EL, Laakso MP, et al: Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. BMJ 2001; 322:1447-1451. (Pubitemid 32575406)
14. Evans, RM, Emsley CL, Gao S, et al. Serum cholesterol, APOE genotype, and the risk of Alzheimer's disease: a populationbased study of African Americans. Neurology 2000; 54: 240-242. (Pubitemid 30038771)
15. Selhub J, Jacques PF, Wilson PF: Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 1993; 270:2693-2698. (Pubitemid 23350966)
16. Seshadri S, Beiser A, Selhub J, et al: Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 2002; 46:476-483. (Pubitemid 34441738)
17. Peila R, Rodriguez BL, Launer LJ: Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu- Asia Aging Study. Diabetes 2002; 51:1256-1262. (Pubitemid 34438377)
18. Hayslett JA, Eichner JE, Yeh JL, et al: Hypertension treatment patterns in American Indians: The Strong Heart Study. Am J Hypertens 2001; 14:950-956. (Pubitemid 32862597)
19. Weiner MF, Rosenberg RN, Womack KB, et al: Atherosclerosis risk factors in American Indians with Alzheimer's Disease. Alzheimer Dis Assoc Disord 2008; 22:245-248.
20. McKhann G, Drachman D, Folstein M, et al: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984; 34:939-944. (Pubitemid 14076461)
21. Morris JC, Heyman A, Mohs RC, et al: The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's Disease. Neurology 1989; 39:1159-1165.
22. Crum RM, Anthony JC, Bassett SS: Population-based norms for the Mini-Mental State Examination by age and educational level. JAMA 1993; 269:2386-2391. (Pubitemid 23129378)
23. Weiner MF, Marquez de la Plata C, Fields JA, et al: Brain MRI, apolipoprotein E genotype, and plasma homocysteine in American Indian Alzheimer disease patients and Indian controls. Curr Alzheimer Res 2009; 6:52-58.
24. Ubbink JB, Hayward Vermaak WJ, Bissbort S: Rapid highperformance liquid chromatographic assay for total homocysteine levels in human serum. J Chromatogr 1991; 565: 441-446.
25. Zar JH (Ed.): Biostatistical Analysis. 4th ed. Upper Saddle River, NJ, Prentice Hall, 1999; pp 223-224, 563-565.
26. Weiner MF, Vega G, Risser RC, et al: Apolipoprotein Ee4, other risk factors, and course of Alzheimer's disease. Biol Psychiatry 1999; 45:633-638. (Pubitemid 29147373)
27. Scḧacter F, Faure-Delanef L, Gúenot F, et al: Genetic associations with human longevity at the APOE and ACE loci. Nat Genet 1994; 6:29-32. (Pubitemid 24191909)
28. Refsum H, Smith AD, Ueland PM, et al: Facts and recommendations about total homocysteine determinations: an expert opinion. Clin Chem 2004; 50:3-32. (Pubitemid 38125696)
29. Qureshi M, Khsandwala H, Haq IU, et al: Elevated levels of plasma homocysteine in hypertensive patients with diabetes mellitus. J Cardiovasc Pharmacol Ther 2003; 8:261-266. (Pubitemid 38045077)
30. Potter K, Hankey GJ, Gren DJ, et al: Homocysteine or renal impairment: which is the real cardiovascular risk factor? Arteriosclerosis Thromb Vasc Biol 2008; 28:1158-1164.
31. Lutz UC: Alterations in homocysteine metabolism among alcohol dependent patients-clinical, pathobiochemical and genetic aspects. Curr Drug Abuse Rev 2008; 1:47-55.
32. Almeida OP, McCaul K, Hankey GH, et al: Homocysteine and depression in later life. Arch Gen Psychiatry 2008; 65:1286-1294.
33. Bangen KJ, Delano-Wood L, Wierenga CE, et al: Associations between stroke risk and cognition in normal aging and Alzheimer's disease with and without depression. Int J Geriatr Psychiatry 2010;25:175-182.
34. Goldstein FC, Ashley AV, Endeshaw YW, et al: Effects of hypertension and hypercholesterolemia on cognitive functioning in patients with Alzheimer disease. Alzheimer Dis Assoc Disord 2001; 22:336-342.
35. Aisen PS, Schneider LS, Sano M, et al: High-dose B Vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial. JAMA 2008; 300:1774-1783